This article by Joffe and Weitz, published in Social Science& Medicine, describes the difficult approval process for Mifepristone and the external challenges to its diffusion into medical practice that have been created , touching upon the role of the pharmaceutical company,  and the conflict between the FDA-approved and an evidence-based regime among other issues.

Link to full text or source